Skip to main content

Pfizer to pay $50M to settle drug wholesalers' EpiPen antitrust claims

By Reuters  
   October 12, 2023

Plaintiffs say settlement avoids risk of claims being tossed on appeal. Pfizer previously settled with consumers for $345 million.

Full story


Get the latest on healthcare leadership in your inbox.